Suchergebnisse - "Uchino, Junji"

PubPharm (9)

1

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Takayama, K. | Ichiki, M. | Tokunaga, S. | +4

2

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Chihara, Y. | Yoshimura, A. | Date, K. | +12

3

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2019

von Chihara, Y. | Date, K. | Takemura, Y. | +10

4

A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Yoshimura, A. | Chihara, Y. | Date, K. | +10

5

Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer : multicenter, open-label, single-arm phase II trial

enthalten in: Investigational new drugs | 2018

von Nakao, A. | Uchino, J. | Igata, F. | +15

6

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2018

von Chihara, Y. | Date, K. | Takemura, Y. | +10

7

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2018

von Chihara, Y. | Date, K. | Takemura, Y. | +10

8

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2018

von Chihara, Y. | Date, K. | Takemura, Y. | +10

9

Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo

enthalten in: Anticancer research | 2008

von Ni, J. | Takayama, K. | Ushijima, R. | +7

1
[1]